Skip to main content


Icon Legend
This session is not in your agenda.
This session is in your agenda. Click to remove it

Full Schedule

Full Schedule

  • Cancelled
  • 18 Month Outcomes from Multicenter RCT: Spinal Cord Stimulation at 10kHz for Non-Surgical Refractory Back Pain
  • A call for implementation of transitional pain services within the perioperative setting: Using a commercial digital telehealth platform to overcome barriers
  • A Comparison of Definitive Urine Drug Test Results for Illicit Drugs in a Sample of People With Chronic Pain Prescribed Opioids to those Not Prescribed Opioids
  • A Forgotten Cause of Bleeding and Musculoskeletal Pain: A Case Report of Contemporary Scurvy
  • A Pilot Clinical and Pharmacokinetic Study of Δ9-Tetrahydrocannabinol (THC) / Cannabidiol (CBD) Nanoparticle Oro-Buccal Spray in Patients with Advanced Cancer Experiencing Uncontrolled Pain.
  • A Rapid Review of Non-Invasive Electromagnetic Devices for the Treatment of Pain
  • A Review of Current Evidence-Based Recommendations of Tramadol for Neuropathic Pain in Adults
  • A Systematic Chemical Design Strategy Leads to NTM-004/005, an Acetaminophen Structural Analog with Minimal Liver Histopathology
  • ADV-484, a Novel Selective Inhibitor of alpha2delta-1 for the Treatment of Neuropathic Pain
  • ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: I. Discovery and Preclinical Evaluation
  • ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: II. Tolerance and Opioid-Induced Hyperalgesia
  • ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: III. Phase-1 Study
  • An epidemiological study of fibromyalgia based on real-world data in a northern city in China
  • Application of Musculoskeletal Ultrasonogram for Same Day Diagnosis and Interventions in the Setting of a Physiatrist’s Office - a Rewarding Experience in Chronic Pain Management.
  • Association between per capita prescribing and abuse of tapentadol and other opioids among individuals entering treatment for opioid use disorders
  • Association of Oral Triptans and Other Common Oral Migraine Treatments With Cardiovascular Outcomes in Patients With a History of Cardiovascular Conditions
  • At-Home Virtual Reality Program for Chronic Low Back Pain: Durability of a Randomized, Placebo-Controlled Trial to 18-months Post-Treatment
  • Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial
  • Bibliometric Analysis of Camphor and Menthol Containing Topical Anesthetics
  • Brucellosis Bursitis : A not so Uncommon yet so Easily Missed Differential Diagnosis of Knee Pain - A Unique Case Report of Symptomatic Dual Knee Bursitis
  • Capsaicin 8% Topical System combined with Electric cell-Signaling Treatment (EcST) for the treatment of Painful Diabetic Peripheral Neuropathy (PDPN) of the feet: a case series
  • Cebranopadol, a Novel Potent Analgesic: Binding Affinity to Opioid Receptors and In Vitro Activity
  • Cebranopadol, a Novel Potent Analgesic: Limitations in Physical Dependence Using Short- and Long-term Rodent Studies
  • Cebranopadol, a Novel Potent Analgesic: Pooled Analysis of Clinical Opiate Withdrawal Scales
  • Cebranopadol, a Novel Potent Analgesic: Review of Clinical Studies Conducted Across Multiple Types of Pain including Chronic Lower Back Bain, Acute Pain, Diabetic Peripheral Neuropathy, and Cancer Pain
  • Celecoxib Oral Solution in the Acute Treatment of Migraine: Pooled Efficacy and Safety Results From 2 Randomized Placebo-controlled Trials
  • CELECOXIB-TRAMADOL HYDROCHLORIDE CO-CRYSTAL IN PATIENTS WITH MODERATE-TO-SEVERE PAIN FOLLOWING BUNIONECTOMY WITH OSTEOTOMY: SECONDARY ANALYSES OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, FACTORIAL, ACTIVE- AND PLACEBO-CONTROLLED TRIAL
  • CELECOXIB-TRAMADOL HYDROCHLORIDE CO-CRYSTAL SAFETY, TOLERABILITY, AND DIFFERENTIAL PHARMACOKINETICS: A SUMMARY OF FIVE PHASE 1 RANDOMIZED CLINICAL TRIALS
  • Clinical Value and Utilization of Pharmacologic, Nonpharmacologic and Self-Healing Therapies: A Pilot Study
  • Cocaethylene: When Cocaine Meets Alcohol
  • Comparison of Radiation Dosages for Lumbar Epidural Injections using Midline and Transforminal Approaches.
  • Consistency of Response to Liquid Celecoxib in Adults With Migraine: Post Hoc Analysis of Results From Two Randomized, Placebo-Controlled Studies
  • Cross-sectional Study of Tampering in an Abuse-Deterrent Formulation of an Extended-Release Opioid in a Treatment Center Population
  • Determining the Representativeness of Participants in a Whole Health Interdisciplinary Chronic Pain Program (PREVAIL) in a VA Medical Center: Who Did We Reach?
  • Development of Machine Learning Algorithms Using EEG Features to Detect Presence of Chronic Pain
  • Differences in the severity of medical outcomes of exposures reported to poison centers involving XTAMPZA® ER and other opioid analgesics
  • Does Current Pain Research Reflect Our Diverse Population?
  • DRUG POSITIVITY AND TRENDS IN CLINICAL INQUIRIES FROM A NATIONAL DRUG MONITORING LABORATORY
  • Early Prediction of Response to INP104 for the Acute Treatment of Migraine
  • Effect of outpatient provider type on the rate of emergency department visits for patients with malignant pain
  • Effectiveness of Battlefield Acupuncture on Pain Outcomes at the Carl Vinson VA Medical Center
  • Efficacy of Celecoxib Oral Solution in Adults With and Without Baseline Nausea: Post-Hoc Analysis of Results From Two Randomized, Double-Blind Placebo-Controlled Trials in the Acute Treatment of Migraine
  • Efficacy of Methylnaltrexone in Patients With Advanced Illness And Opioid-Induced Constipation Refractory to Conventional Laxatives: Impact Of Baseline Laxative Use
  • Enkephalin as a Novel Analgesic: Efficacy and Safety in Pre-Clinical Models
  • Evaluating the Literacy Levels of Opioid Agreements
  • Evaluation of Ketamine Infusions in Chronic Pain Patients at TVHS
  • Exploratory Efficacy of INP104 in Migraine Patients By Prior Treatment
  • Exploratory Efficacy of INP104 in Patients Using Concomitant Preventive Migraine Medications
  • Gender Disparity Persists in Pain Medicine: A Cross-Sectional Study of Chairpersons within ACGME-Accredited Chronic Pain Fellowship Programs in the United States
  • Impact of Celecoxib Oral Solution on Symptomatic Improvements in the Acute Treatment of Migraine
  • Impact of Patient Subgroups on the Efficacy of Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness
  • Improvements in Productivity and Disability With INP104 as Assessed by the Migraine Disability Assessment Scale (MIDAS): Results From the Phase 3 STOP 301 Study
  • LX9211, a Novel Therapeutic Approach to Treatment of Neuropathic Pain
  • Mobile Health Technology & Pain Management
  • Naloxegol Provides Clinically Meaningful Healthcare Related Quality of Life (HR-QOL) Improvement in Patients with Opioid-Induced Constipation (OIC): A Pooled Analysis of Two Global Phase 3 Studies of Naloxegol
  • Naloxegol Provides Clinically Meaningful Symptom Improvement in Patients with Opioid-Induced Constipation (OIC): A Pooled Analysis of Two Global Phase 3 Studies of Naloxegol
  • Non-Medical Use of XTAMPZA ER: Motivation, Methods, and Perceptions of Tampering
  • Opioid Prescription Dispensing Patterns Among Patients With Schizophrenia or Bipolar Disorder
  • OTC Analgesics Knowledge, or Lack Thereof
  • Patterns of Urine Drug Screen Inconsistency in Patients Referred to Establish Care for Chronic Pain: Why are Many Patients Positive for Buprenorphine?
  • Posterior femoral cutaneous nerve neuropathy post marathon: a case report
  • Potent anti-inflammatory effects of an H2S-releasing naproxen (ATB-346) in a human model of inflammation
  • Prescription Opioid Nonmedical Use via Oral Manipulation: An Under-Recognized Risk
  • PREVAIL: Development of a Whole Health Interdisciplinary Evaluation of Chronic Pain in a Rural VA Medical Center
  • Real-World Effectiveness of Ubrogepant for the Acute Treatment of Migraine in Combination With OnabotulinumtoxinA Preventive: Results From the COURAGE Study
  • Response to Treatment with Lemborexant in Older Subjects with Insomnia Disorder and Comorbid Pain at Baseline
  • Selective Inhibition of NaV1.8 with VX-548 as a Targeted Treatment for Acute Pain
  • Targeted Muscle Reinnervation for the Treatment of Complex Regional Pain Syndrome in the Lower Extremity
  • The Agnostic Respiratory Stimulant ENA-001 Demonstrates Preliminary Positive Results in an Animal Model of Apnea of Prematurity
  • The Heat is On: When Hot Weather Hurts
  • The Impact of an Audio-Visual Stimulation Device on Quality of Life and Clinical Symptoms in Participants with Fibromyalgia
  • The Role of Over-the-Counter Pain Relivers for Self-Care in America’s Changing Healthcare Landscape
  • Treatment Effects of Celecoxib Oral Solution in Migraine With Aura and Without Aura: Post-Hoc Analysis of Results From Two Randomized, Double-Blind Placebo-Controlled Trials
  • Treatment of Painful Diabetic Neuropathy (PDN): High-Frequency (10 kHz) Spinal Cord Stimulation (SCS) Provides Significant, Durable Pain Relief for PDN Patients
  • udget Impact Analysis of Xtampza® ER (oxycodone extended-release) for the Treatment of Chronic Pain from a Managed Care Perspective
  • Ultrasound-guided transversus abdominis plane block with liposomal bupivacaine in patients undergoing elective cesarean section via spinal anesthesia
  • Update on NTM-006, a Novel Orally-Active Non-Opioid Analgesic: Molecular-Modeling Consistent with Allosteric Modulation of the Adenosine A3 Receptor
  • When an Old Drug Brings New Challenges: Nitazenes
  • Monday, September 5, 2022
  • 6:00 PM – 8:00 PM
    PAINWeek 101
  • Tuesday, September 6, 2022
  • 7:30 AM – 8:20 AM
    How Green Is My Valley: Newly Discovered Cannabinoids and Their Possible Medical Uses
  • 7:30 AM – 8:20 AM
    Trash the Stash: Safe Opioid Disposal
  • 7:30 AM – 8:20 AM
    What's Eating You? The Complexities of Eating Disorders and Chronic Pain
  • 8:30 AM – 9:30 AM
    Fighting Fire With Fire! Join us for a Spicy Breakfast and a Conversation about Care Challenges in Treating Painful Diabetic Neuropathy of the Feet
  • 9:40 AM – 10:30 AM
    Invisible Privileges: How to Rebalance the Provider-Patient Relationship in Marginalized Populations
  • 9:40 AM – 10:30 AM
    Pain on the Brain: Pharmacotherapy for Central Post-Stroke Pain
  • 9:40 AM – 10:30 AM
    Point Blank: Demystifying Entrapment Neuropathies
  • 9:40 AM – 10:30 AM
    The Tingler: Evidence Based Minimally Invasive Interventions for Chronic Low Back Pain
  • 11:00 AM – 11:50 AM
    The Sum of Its Parts: The Concept of Total Pain
  • 11:00 AM – 11:50 AM
    The Upside Down: Fear-Avoidance & Chronic Pain
  • 12:30 PM – 1:30 PM
    Think Talk Treat Migraine
  • 1:40 PM – 2:30 PM
    ‘Itch Please! Going Beyond Antihistamines for Pruritus in Patients with Pain or Advanced Illness
  • 1:40 PM – 2:30 PM
    Look for Zebras Not Horses: Rare Disease and Pain Management
  • 1:40 PM – 2:30 PM
    Neurogenic Thoracic Outlet Syndrome
  • 1:40 PM – 2:30 PM
    Tea for Two: Empathy vs Sympathy
  • 2:40 PM – 3:30 PM
    A Pain in the Aspirin! Revisiting the OTC Analgesic Aisle
  • 2:40 PM – 3:30 PM
    Chronic Post Surgical Pain: Risk Assessment and Mitigation
  • 2:40 PM – 3:30 PM
    Landscape of Wonders: Injections, Nerve Blocks, Pumps, and Neuromodulation
  • 2:40 PM – 3:30 PM
    The Crucible: Update on Complex Regional Pain Syndrome
  • 3:40 PM – 4:30 PM
    Put Your Chronic Low Back Pain Patients on the Path to Relief
  • 3:40 PM – 4:30 PM
    Setting the bar higher: Think you know DHE? Think again.
  • 4:40 PM – 5:30 PM
    A Simple Twist of Fate: Understanding Whiplash Risk Factors & Treatment
  • 4:40 PM – 5:30 PM
    How to Get to Sesame Street: Reducing the Stigma Attached to Chronic Pain
  • 4:40 PM – 5:30 PM
    The Secret Garden: Health Coaching, Hope, and Healing Through Crisis
  • 4:40 PM – 5:30 PM
    Wolf at the Door: Pain and Substance Use Disorders
  • 5:40 PM – 6:30 PM
    Day for Night: Changing the Pain Experience When Living Life With Persistent Pain
  • 5:40 PM – 6:30 PM
    Everything is Illuminated: Cannabis and Cannabinoids for Muscular, Joint, Neuropathic, and Migraine Pain
  • Wednesday, September 7, 2022
  • 7:30 AM – 8:20 AM
    Lo and Behold: The Clinical Nurse Anesthetist Experience in Pain Management
  • 7:30 AM – 8:20 AM
    Pain Pathways Made Simple
  • 7:30 AM – 8:20 AM
    Perioperative Pain Management in Opioid Use Disorder
  • 8:30 AM – 9:30 AM
    Collegium
  • 9:40 AM – 10:30 AM
    Chronic Pain Assessment
  • 9:40 AM – 10:30 AM
    The Big Muddy: Why Clinical Trials Fail
  • 9:40 AM – 10:30 AM
    Treating the Opiophilic Patient: Strategies for Enhancing Communication, Education, & Outcomes
  • 11:00 AM – 11:50 AM
    Clinical Pearls: Unraveling the Secrets of Imaging Studies
  • 11:00 AM – 11:50 AM
    Green Acres: Pregnancy & Pain in Rural Communities
  • 11:00 AM – 11:50 AM
    The Inheritance Conundrum: What to Do With Legacy Chronic Pain Patients
  • 12:30 PM – 1:30 PM
    Pharmacom
  • 1:40 PM – 2:30 PM
    Hell's Kitchen: How We Address DEA Red Flags
  • 1:40 PM – 2:30 PM
    Neuromodulation for Advanced Practice Providers
  • 1:40 PM – 2:30 PM
    The Persistence of Memory: DEA Registrant Responsibilities After the United States Supreme Court's Decision in Xiulu Ruan V. United States of America
  • 2:40 PM – 3:30 PM
    Bridging the Gap: The Transitional Pain Service and Role of the NP
  • 2:40 PM – 3:30 PM
    Eye of the Storm: The Debate on Opioid Public Policy
  • 2:40 PM – 3:30 PM
    The Long and Winding Road: Cognitive Behavioral Therapy for Opioid Use Disorder
  • 3:40 PM – 4:30 PM
    Scratching the Surface: A Review of Rx & OTC Topical Pain Medication
  • 3:40 PM – 4:30 PM
    Ten Action Items to Combat Peer to Peer and Institutional Racial Bias in Medicine
  • 3:40 PM – 4:30 PM
    The PA Perspective on Owning Your Own Practice
  • 4:40 PM – 5:30 PM
    Meet Me at the Corner of Opportunity and Adversity: A Tribute to Jeffrey Fudin
  • 5:30 PM – 7:30 PM
    Welcome Reception
  • Thursday, September 8, 2022
  • 7:30 AM – 8:20 AM
    Alphabet Soup: Updates on GABA Abuse and Legislation
  • 7:30 AM – 8:20 AM
    Rubies and Rust: Menstruation as The Great Disrupter
  • 7:30 AM – 8:20 AM
    The Peter Panification of Chronic Pain and Search for Identity
  • 8:30 AM – 9:30 AM
    Salix
  • 9:40 AM – 10:30 AM
    Diamond Headache Clinic: Epidemiology and Diagnosis
  • 9:40 AM – 10:30 AM
    East v. West: Who Should Hold the Needle First? An Acupuncturist and an Interventional Pain Specialist Debate
  • 9:40 AM – 10:30 AM
    No Time Like the Past! The Imprecision of the Postoperative Pain Score
  • 9:40 AM – 10:30 AM
    One Candle, Two Wicks:: Managing Female Sexual Pain and Dysfunction
  • 11:00 AM – 11:50 AM
    Diamond Headache Clinic: Prevention Treatment
  • 11:00 AM – 11:50 AM
    Telehealth for Pain Providers: Necessary Attributes for a Successful Clinical Practice
  • 11:00 AM – 11:50 AM
    The Plot Thickens The Impact of Opioid Litigation on Main Street Practitioner
  • 11:00 AM – 11:50 AM
    The Scarlet Letter: Stigma and Patient Outcomes
  • 12:30 PM – 1:30 PM
    A Portfolio of Treatment for Migraine Patients
  • 1:40 PM – 2:30 PM
    Diamond Headache Clinic: Acute Treatment
  • 1:40 PM – 2:30 PM
    Duck Soup: Multidisciplinary Pain Management in 2022
  • 1:40 PM – 2:30 PM
    The Big Muddy: Why Clinical Trials Fail (Encore)
  • 1:40 PM – 2:30 PM
    The Skeleton Key: Failed Back Surgery Syndrome and Spinal Cord Stimulation
  • 2:40 PM – 3:30 PM
    Atomic Secrets: Regenerative Medicine in Managing Chronic Pain
  • 2:40 PM – 3:30 PM
    Cyborgs Among Us: Will We All Be Bionic?
  • 2:40 PM – 3:30 PM
    The Gut-Brain Axis: Aligning the Three Brains to Resolve Pain
  • 2:40 PM – 3:30 PM
    The Two of Us: Opioids and Cannabinoids in Pain Management
  • 3:40 PM – 4:30 PM
    SEGLENTIS® (celecoxib 56 mg and tramadol hydrochloride 44 mg) C-IV: The first and only multimodal co-crystal for the treatment of acute pain in appropriate patients
  • 4:40 PM – 5:30 PM
    An Affair to Remember: The Case of the Perplexing Patient
  • 4:40 PM – 5:30 PM
    Awkward Conversations: Managing Patients With Chronic Pain
  • 4:40 PM – 5:30 PM
    Shadows and Fog: Biomedical and Psychosocial Considerations of Pelvic Pain
  • 4:40 PM – 5:30 PM
    The Ink Is Black, The Page Is White: How Racism, Stereotyping, and Social Status Impact Pain Management
  • 5:40 PM – 6:30 PM
    Help! Resources for Managing Female Chronic Pelvic Pain in a Busy Clinical Practice
  • 5:40 PM – 6:30 PM
    Microinduction to Buprenorphine from Methadone for Chronic Pain: Outpatient Protocol With Case Examples
  • 5:40 PM – 6:30 PM
    The Lowdown: Rethinking the Role of Interventional Pain Management
  • 6:30 PM – 8:30 PM
    Poster Reception
  • Friday, September 9, 2022
  • 7:30 AM – 8:20 AM
    Podium Presentations
  • 7:30 AM – 8:20 AM
    Sunshine of Your Love: How a Heart-Centered Approach Can Conquer Chronic Pain
  • 7:30 AM – 8:20 AM
    The Breath of Life: Practical Tools for the Pain Clinician - Breath Work and Movement
  • 7:30 AM – 8:20 AM
    Under the Volcano: Pain Management in Special Populations
  • 8:30 AM – 9:30 AM
    Collegium
  • 9:40 AM – 10:30 AM
    Highway 61 Revisited: Marijuana, Medication Assisted Treatment, and Pain Management Today and Beyond
  • 9:40 AM – 10:30 AM
    The Glass Bead Game: Harm Reduction and Its Potential Impact on the Opioid Crisis
  • 9:40 AM – 10:30 AM
    Touch or Technology: How Physical Are Physical Exams?
  • 9:40 AM – 10:30 AM
    Word Salad: Contextual Factors and Their Effect on Therapeutic Outcomes
  • 11:00 AM – 11:50 AM
    Bang the Drum Loudly: Teaching Self-Management of Peripheral Musculoskeletal Nerve Sensitization
  • 11:00 AM – 11:50 AM
    Old Friends With New Faces: Practical Use of 2nd & 3rd Line Anticonvulsants for Neuropathic Pain Conditions
  • 11:00 AM – 11:50 AM
    The Groundhog Day Phenomenon Reloaded
  • 11:00 AM – 11:50 AM
    The Petrified Forest: Sacroiliac Joint Dysfunction and Treatment Update
  • 12:30 PM – 1:30 PM
    Severe pain, strategic perspectives
  • 1:40 PM – 2:30 PM
    I Walk the Line: The Fine Balance of Geriatric Pain Management
  • 1:40 PM – 2:30 PM
    Secrets and Lies: The Truth About Buprenorphine
  • 1:40 PM – 2:30 PM
    Virtual Reality for the Primary Care Physician
  • 1:40 PM – 3:30 PM
    Back Pain: It's All About Diagnosis
  • 2:40 PM – 3:30 PM
    Purple Haze: Mysticism & Science of Psychedelics
  • 2:40 PM – 3:30 PM
    Ring of Fire: COVID and the Opioid Epidemic. Part II
  • 2:40 PM – 3:30 PM
    Take 2 Zaps and Call Me in the Morning: Electroceuticals in Headache Management
  • 2:40 PM – 3:30 PM
    When Stars Align: The New Era of Peripheral Nerve Stimulation
  • 3:40 PM – 4:30 PM
    Hugs vs Drugs: Debating the 2022 CDC Opioid Prescribing Guidelines
  • 3:40 PM – 4:30 PM
    K Especial: The Biopsychosocial Model of Personalizing Ketamine for Pain Management
  • 3:40 PM – 4:30 PM
    Management of Chronic Abdominal Pain. Treatment Algorithm
  • 4:40 PM – 5:30 PM
    An Integrative Osteopathic Approach to Opioid Use Disorder
  • 4:40 PM – 5:30 PM
    Measuring Recovery Outcomes after a Fall Injury: Pragmatic Approach from Physiatry Perspective
  • 4:40 PM – 5:30 PM
    Super-Tolerance! Managing Patients With Active Opioid Use Disorder